Search Results

There are 7685 results for: content related to: New natural history of interferon-β–treated relapsing multiple sclerosis

  1. You have full text access to this OnlineOpen article
    Beta-interferon exposure and onset of secondary progressive multiple sclerosis

    European Journal of Neurology

    Volume 22, Issue 6, June 2015, Pages: 990–1000, T. Zhang, A. Shirani, Y. Zhao, M. E. Karim, P. Gustafson, J. Petkau, C. Evans, E. Kingwell, M. van der Kop, F. Zhu, J. Oger, H. Tremlett and BC MS Clinic Neurologists

    Version of Record online : 6 APR 2015, DOI: 10.1111/ene.12698

  2. Real-life impact of early interferonβ therapy in relapsing multiple sclerosis

    Annals of Neurology

    Volume 66, Issue 4, October 2009, Pages: 513–520, M. Trojano, F. Pellegrini, D. Paolicelli, A. Fuiani, G.B. Zimatore, C. Tortorella, I.L. Simone, F. Patti, A. Ghezzi, V. Zipoli, P. Rossi, C. Pozzilli, G. Salemi, A. Lugaresi, R. Bergamaschi, E. Millefiorini, M. Clerico, G. Lus, M. Vianello, C. Avolio, P. Cavalla, V. Lepore, P. Livrea, G. Comi and M.P. Amato

    Version of Record online : 28 MAY 2009, DOI: 10.1002/ana.21757

  3. Predictors of long-term outcome in multiple sclerosis patients treated with interferon beta

    Annals of Neurology

    Volume 73, Issue 1, January 2013, Pages: 95–103, Robert A. Bermel, Xiaojun You, Pamela Foulds, Robert Hyde, Jack H. Simon, Elizabeth Fisher and Richard A. Rudick

    Version of Record online : 1 FEB 2013, DOI: 10.1002/ana.23758

  4. You have full text access to this OnlineOpen article
    Effectiveness of glatiramer acetate compared to other multiple sclerosis therapies

    Brain and Behavior

    Volume 5, Issue 6, June 2015, Guillermo Izquierdo, Nuria García-Agua Soler, Macarena Rus and Antonio José García-Ruiz

    Version of Record online : 1 MAY 2015, DOI: 10.1002/brb3.337

  5. Benign multiple sclerosis: a need for a consensus

    Acta Neurologica Scandinavica

    Volume 122, Issue s190, July 2010, Pages: 44–50, S. B. Glad, J. H. Aarseth, H. Nyland, T. Riise and K.-M. Myhr

    Version of Record online : 2 JUN 2010, DOI: 10.1111/j.1600-0404.2010.01375.x

  6. You have free access to this content
    Teriflunomide for multiple sclerosis

    Intervention Review

    The Cochrane Library

    Dian He, Chao Zhang, Xia Zhao, Yifan Zhang, Qingqing Dai, Yuan Li and Lan Chu

    Published Online : 22 MAR 2016, DOI: 10.1002/14651858.CD009882.pub3

  7. Cerebellar deficit and respiratory impairment: a strong associationin multiple sclerosis?

    Acta Neurologica Scandinavica

    Volume 101, Issue 2, February 2000, Pages: 98–103, M. G. Grasso, S. Lubich, L. Guidi, D. Rinnenburger and S. Paolucci

    Version of Record online : 24 DEC 2001, DOI: 10.1034/j.1600-0404.2000.101002098.x

  8. Analysis of T2 Intensity by Magnetic Resonance Imaging of Deep Gray Matter Nuclei in Multiple Sclerosis Patients: Effect of Immunomodulatory Therapies

    Journal of Neuroimaging

    Volume 22, Issue 2, April 2012, Pages: 137–144, Siddharama Pawate, Lily Wang, Yanna Song and Subramaniam Sriram

    Version of Record online : 24 JUN 2011, DOI: 10.1111/j.1552-6569.2011.00622.x

  9. You have free access to this content
    Poster Session-Sunday

    European Journal of Neurology

    Volume 23, Issue S2, June 2016, Pages: 345–600,

    Version of Record online : 23 JUN 2016, DOI: 10.1111/ene.13093

  10. Maintenance plasma exchange therapy for steroid-refractory neuromyelitis optica

    Journal of Clinical Apheresis

    Volume 27, Issue 4, 2012, Pages: 183–192, Bhupendra O. Khatri, John Kramer, Mary Dukic, Mauricio Palencia and William Verre

    Version of Record online : 9 APR 2012, DOI: 10.1002/jca.21215

  11. You have free access to this content
    Paper Poster Sessions

    European Journal of Neurology

    Volume 21, Issue s1, May 2014, Pages: 388–713,

    Version of Record online : 28 MAY 2014, DOI: 10.1111/ene.12497

  12. You have free access to this content
    Poster Session-Saturday

    European Journal of Neurology

    Volume 23, Issue S2, June 2016, Pages: 111–344,

    Version of Record online : 23 JUN 2016, DOI: 10.1111/ene.13092

  13. You have full text access to this OnlineOpen article
    Natalizumab improves ambulation in relapsing−remitting multiple sclerosis: results from the prospective TIMER study and a retrospective analysis of AFFIRM

    European Journal of Neurology

    Volume 22, Issue 3, March 2015, Pages: 570–577, N. Voloshyna, E. Havrdová, M. Hutchinson, T. Nehrych, X. You, S. Belachew, C. Hotermans and D. Paes

    Version of Record online : 15 DEC 2014, DOI: 10.1111/ene.12618

  14. Therapeutic outcome 3 years after switching of immunomodulatory therapies in patients with relapsing–remitting multiple sclerosis in Argentina

    European Journal of Neurology

    Volume 15, Issue 4, April 2008, Pages: 386–393, A. Carrá, P. Onaha, G. Luetic, M. Burgos, E. Crespo, N. Deri, M. Halfon, G. Jaacks, A. López, V. Sinay and C. Vrech

    Version of Record online : 18 MAR 2008, DOI: 10.1111/j.1468-1331.2008.02071.x

  15. You have free access to this content
    Flash Posters

    European Journal of Neurology

    Volume 22, Issue S1, June 2015, Pages: 484–828,

    Version of Record online : 29 JUN 2015, DOI: 10.1111/ene.12808

  16. Predictors of long-term disability accrual in relapse-onset multiple sclerosis

    Annals of Neurology

    Volume 80, Issue 1, July 2016, Pages: 89–100, Vilija G. Jokubaitis, Tim Spelman, Tomas Kalincik, Johannes Lorscheider, Eva Havrdova, Dana Horakova, Pierre Duquette, Marc Girard, Alexandre Prat, Guillermo Izquierdo, Pierre Grammond, Vincent Van Pesch, Eugenio Pucci, François Grand'Maison, Raymond Hupperts, Franco Granella, Patrizia Sola, Roberto Bergamaschi, Gerardo Iuliano, Daniele Spitaleri, Cavit Boz, Suzanne Hodgkinson, Javier Olascoaga, Freek Verheul, Pamela McCombe, Thor Petersen, Csilla Rozsa, Jeannette Lechner-Scott, Maria Laura Saladino, Deborah Farina, Pietro Iaffaldano, Damiano Paolicelli, Helmut Butzkueven, Alessandra Lugaresi, Maria Trojano and on behalf of the MSBase Study Group

    Version of Record online : 1 JUN 2016, DOI: 10.1002/ana.24682

  17. Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing–remitting multiple sclerosis

    European Journal of Neurology

    Volume 22, Issue 3, March 2015, Pages: 564–569, E. Thouvenot, M. Orsini, J.-P. Daures and W. Camu

    Version of Record online : 20 DEC 2014, DOI: 10.1111/ene.12617

  18. A single-arm, open-label study of alemtuzumab in treatment-refractory patients with multiple sclerosis

    European Journal of Neurology

    Volume 19, Issue 2, February 2012, Pages: 307–311, E. J. Fox, H. C. Sullivan, S. K. Gazda, L. Mayer, L. O’Donnell, K. Melia and S. L. Lake

    Version of Record online : 7 SEP 2011, DOI: 10.1111/j.1468-1331.2011.03507.x

  19. A prospective, open-label treatment trial to compare the effect of IFN β-1a (Avonex), IFNβ-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing-remitting multiple sclerosis

    European Journal of Neurology

    Volume 8, Issue 2, March 2001, Pages: 141–148, O. A. Khan, A. C. Tselis, J. A. Kamholz, J. Y. Garbern, R. A. Lewis and R. P. Lisak

    Version of Record online : 7 JUL 2008, DOI: 10.1046/j.1468-1331.2001.00189.x

  20. Effectiveness of interferon beta treatment in relapsing-remitting multiple sclerosis: an Italian cohort study

    Journal of Evaluation in Clinical Practice

    Volume 10, Issue 4, November 2004, Pages: 511–518, Pierluigi Russo, Andrea Paolillo, Luciano Caprino, Stefano Bastianello and Placido Bramanti

    Version of Record online : 8 OCT 2004, DOI: 10.1111/j.1365-2753.2003.00436.x